- Home
- / Rasna Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Rasna Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$3.1 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| General and administrative expense | 40.0K | 16.8K | 62.2K | 1.0M | 2.5M | 598.8K | 463.6K | 247.8K | 300.1K | 287.4K |
| Operating expense total | 40.0K | 16.8K | 62.2K | 4.5M | 4.1M | 613.1K | 2.6M | 383.9K | 379.6K | |
| EBIT | (62.2K) | (4.5M) | (4.1M) | (915.2K) | (5.4M) | (247.8K) | 141.1K | (4.2M) | ||
| Interest expense | 27.6K | 41.4K | 1.1K | |||||||
| Pre tax profit | (62.2K) | (4.4M) | (4.1M) | (944.0K) | (5.3M) | (785.1K) | (686.6K) | (4.4M) | ||
| Income tax expense | 2.1K | (7.6K) | (3.0K) | |||||||
| Net Income | (40.0K) | (16.8K) | (62.2K) | (4.4M) | (4.1M) | (936.4K) | (5.3M) | (785.1K) | (686.6K) | (4.4M) |
| EPS | 0.0 | 0.0 |